Specificity of short interfering RNA determined through gene expression signatures

Short interfering RNA (siRNA) is widely used for studying gene function and holds great promise as a tool for validating drug targets and treating disease. A critical assumption in these applications is that the effect of siRNA on cells is specific, i.e., limited to the specific knockdown of the target gene. In this article, we characterize the specificity of siRNA by applying gene expression profiling. Several siRNAs were designed against different regions of the same target gene for three different targets. Their effects on cells were compared by using DNA microarrays to generate gene expression signatures. When the siRNA design and transfection conditions were optimized, the signatures for different siRNAs against the same target were shown to correlate very closely, whereas the signatures for different genes revealed no correlation. These results indicate that siRNA is a highly specific tool for targeted gene knockdown, establishing siRNA-mediated gene silencing as a reliable approach for large-scale screening of gene function and drug target validation.

[1]  Judy Lieberman,et al.  RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.

[2]  Phillip A Sharp,et al.  siRNAs can function as miRNAs , 2003 .

[3]  Jiri Bartek,et al.  53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer , 2002, Nature Cell Biology.

[4]  Michael T. McManus,et al.  Small Interfering RNA-Mediated Gene Silencing in T Lymphocytes1 , 2002, The Journal of Immunology.

[5]  Phillip D Zamore,et al.  Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. , 2002, Molecular cell.

[6]  B. Stillman,et al.  Orc6 Involved in DNA Replication, Chromosome Segregation, and Cytokinesis , 2002, Science.

[7]  R. Pomerantz.  RNA interference meets HIV-1: Will silence be golden? , 2002, Nature Medicine.

[8]  R. Juliano,et al.  Evaluating the Specificity of Antisense Oligonucleotide Conjugates , 2002, The Journal of Biological Chemistry.

[9]  Catherine L Day,et al.  HtrA--a renaissance protein. , 2002, Structure.

[10]  Yoon-Jae Song,et al.  Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: A DNA microarray analysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[12]  Y. Kalma,et al.  E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis , 2002, Oncogene.

[13]  K Weber,et al.  Identification of essential genes in cultured mammalian cells using small interfering RNAs. , 2001, Journal of cell science.

[14]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Tuschl,et al.  Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate , 2001, The EMBO journal.

[16]  G. Hannon,et al.  The rest is silence. , 2001, RNA.

[17]  Phillip D. Zamore,et al.  RNA interference: listening to the sound of silence , 2001, Nature Structural Biology.

[18]  K. Becker,et al.  Antisense DNAs as multisite genomic modulators identified by DNA microarray , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Fire,et al.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[21]  Y. Kalma,et al.  Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2 , 2001, Oncogene.

[22]  P. Sharp,et al.  RNA interference--2001. , 2001, Genes & development.

[23]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[24]  I Lebedeva,et al.  Antisense oligonucleotides: promise and reality. , 2001, Annual review of pharmacology and toxicology.

[25]  I. Brukner,et al.  Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development of a new in vitro assay. , 2000, Biochemistry.

[26]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[27]  J. Harbour,et al.  Rb function in cell-cycle regulation and apoptosis , 2000, Nature Cell Biology.

[28]  S. Crooke,et al.  Molecular mechanisms of action of antisense drugs. , 1999, Biochimica et biophysica acta.

[29]  J. Lis,et al.  RNA aptamers as effective protein antagonists in a multicellular organism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Turner,et al.  Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs. , 1998, Biochemistry.

[31]  A. Branch,et al.  A good antisense molecule is hard to find , 1998 .

[32]  C. Stein,et al.  Does antisense exist? , 1995, Nature Medicine.